On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
49° Feels Like: 47°
Wind: SSE 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 45°

Tomorrow

Partly Cloudy 66°

Wed Night

Showers 54°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Gilead says on track with hepatitis C treatments

(Reuters) - Gilead Sciences Inc is on track to file for regulatory approval of sofosbuvir, its treatment for chronic hepatitis C virus (HCV) infection, starting in mid-2013, the biotech company said on Monday.

Gilead is scheduled to give investors an update on its candidates for HCV treatment at a JPMorgan healthcare conference this week in San Francisco.

The company will discuss new results from an arm of a continuing Phase 2 trial and provide a progress report on a range of Phase 2 and 3 trials evaluating a once-daily fixed-dose combination tablet of the medicines.

(Reporting by Debra Sherman; editing by John Wallace)

Comments